|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pasin E, Josephson DY, Mitra AP, Cote RJ
and Stein JP: Superficial bladder cancer: An update on etiology,
molecular development, classification, and natural history. Rev
Urol. 10:31–43. 2008.PubMed/NCBI
|
|
4
|
Yun SJ and Kim WJ: Role of the
epithelial-mesenchymal transition in bladder cancer: From prognosis
to therapeutic target. Korean J Urol. 54:645–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baumgart E, Cohen MS, Neto Silva B, Jacobs
MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M,
Libertino JA and Summerhayes IC: Identification and prognostic
significance of an epithelial-mesenchymal transition expression
profile in human bladder tumors. Clin Cancer Res. 13:1685–1694.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McConkey DJ, Choi W, Marquis L, Martin F,
Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al: Role
of epithelial-to-mesenchymal transition (EMT) in drug sensitivity
and metastasis in bladder cancer. Cancer Metastasis Rev.
28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: A role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995,
Discussion-5995. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu GL, Yang HJ, Liu T and Lin YZ:
Expression and significance of E-cadherin, N-cadherin, transforming
growth factor-β1 and Twist in prostate cancer. Asian Pac J Trop
Med. 7:76–82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development and disease. J Cell Biol. 172:973–981. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB,
Liu W, Qi Q, Lu N, Tao L, Wang XT, et al: Isolation and
characterization of cancer stem like cells in human glioblastoma
cell lines. Cancer Lett. 279:13–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Greenburg G and Hay ED: Epithelia
suspended in collagen gels can lose polarity and express
characteristics of migrating mesenchymal cells. J Cell Biol.
95:333–339. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wheelock MJ and Johnson KR: Cadherins as
modulators of cellular phenotype. Annu Rev Cell Dev Biol.
19:207–235. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nollet F, Kools P and van Roy F:
Phylogenetic analysis of the cadherin superfamily allows
identification of six major subfamilies besides several solitary
members. J Mol Biol. 299:551–572. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rangel MC, Karasawa H, Castro NP, Nagaoka
T, Salomon DS and Bianco C: Role of Cripto-1 during
epithelial-to-mesenchymal transition in development and cancer. Am
J Pathol. 180:2188–2200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jeanes A, Gottardi CJ and Yap AS:
Cadherins and cancer: How does cadherin dysfunction promote tumor
progression? Oncogene. 27:6920–6929. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Derksen PW, Liu X, Saridin F, van der
Gulden H, Zevenhoven J, Evers B, van Beijnum JR, Griffioen AW, Vink
J, Krimpenfort P, et al: Somatic inactivation of E-cadherin and p53
in mice leads to metastatic lobular mammary carcinoma through
induction of anoikis resistance and angiogenesis. Cancer Cell.
10:437–449. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lehembre F, Yilmaz M, Wicki A, Schomber T,
Strittmatter K, Ziegler D, Kren A, Went P, Derksen PW, Berns A, et
al: NCAM-induced focal adhesion assembly: A functional switch upon
loss of E-cadherin. Embo J. 27:2603–2615. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Perl AK, Wilgenbus P, Dahl U, Semb H and
Christofori G: A causal role for E-cadherin in the transition from
adenoma to carcinoma. Nature. 392:190–193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Packer AI, Elwell VA, Parnass JD, Knudsen
KA and Wolgemuth DJ: N-cadherin protein distribution in normal
embryos and in embryos carrying mutations in the homeobox gene
Hoxa-4. Int J Dev Biol. 41:459–468. 1997.PubMed/NCBI
|
|
23
|
Hazan RB, Kang L, Whooley BP and Borgen
PI: N-cadherin promotes adhesion between invasive breast cancer
cells and the stroma. Cell Adhes Commun. 4:399–411. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Derycke LD and Bracke ME: N-cadherin in
the spotlight of cell-cell adhesion, differentiation,
embryogenesis, invasion and signalling. Int J Dev Biol. 48:463–476.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jennbacken K, Tesan T, Wang W, Gustavsson
H, Damber JE and Welen K: N-cadherin increases after androgen
deprivation and is associated with metastasis in prostate cancer.
Endocr Relat Cancer. 17:469–479. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
De Wever O, Pauwels P, De Craene B, Sabbah
M, Emami S, Redeuilh G, Gespach C, Bracke M and Berx G: Molecular
and pathological signatures of epithelial-mesenchymal transitions
at the cancer invasion front. Histochem Cell Biol. 130:481–494.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maeda M, Johnson KR and Wheelock MJ:
Cadherin switching: Essential for behavioral but not morphological
changes during an epithelium-to-mesenchyme transition. J Cell Sci.
118:873–887. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bryan RT and Tselepis C: Cadherin
switching and bladder cancer. J Urol. 184:423–431. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bryan RT, Atherfold PA, Yeo Y, Jones LJ,
Harrison RF, Wallace DM and Jankowski JA: Cadherin switching
dictates the biology of transitional cell carcinoma of the bladder:
Ex vivo and in vitro studies. J Pathol. 215:184–194. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lascombe I, Clairotte A, Fauconnet S,
Bernardini S, Wallerand H, Kantelip B and Bittard H: N-cadherin as
a novel prognostic marker of progression in superficial urothelial
tumors. Clin Cancer Res. 12:2780–2787. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Adam L, Zhong M, Choi W, Qi W, Nicoloso M,
Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, et al:
miR-200 expression regulates epithelial-to-mesenchymal transition
in bladder cancer cells and reverses resistance to epidermal growth
factor receptor therapy. Clin Cancer Res. 15:5060–5072. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Muramaki M, Miyake H, Terakawa T, Kumano
M, Sakai I and Fujisawa M: Expression profile of E-cadherin and
N-cadherin in non-muscle-invasive bladder cancer as a novel
predictor of intravesical recurrence following transurethral
resection. Urol Oncol. 30:161–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
